• X-Gal as a Decision Tool for Molecular Biology

  2026-09-16

  X-Gal is more than a blue-white colony screening reagent: it is an evidence layer for construct triage and reporter validation. This article connects its chemistry and lacZα complementation logic with assay decisions inspired by recent iRhom2 olfaction research.

• Azithromycin: Mechanism, Benchmarks, and Workflows

  2026-09-16

  Azithromycin is a macrolide antibiotic and bacterial protein synthesis inhibitor used in bacterial infection research and antimicrobial resistance studies. Its 23S rRNA binding mechanism is well established, while peptide-specific MIC data, trypanosomosis animal-model findings, and formulation properties require condition-specific interpretation.

• Bestatin (Ubenimex): Reliable Cell Assays

  2026-09-15

  A scenario-based guide to using Bestatin (Ubenimex), SKU A2575, in viability, apoptosis, aminopeptidase activity, and multidrug resistance workflows. It connects biochemical selectivity with practical solvent, dosing, control, and vendor-selection decisions.

• AO/PI Staining Solution for Reliable Cell Counting

  2026-09-14

  AO/PI Staining Solution uses two fluorescent DNA dyes to distinguish membrane-intact and membrane-compromised cells during fluorescence-based cell counting. The dual-stain format supports a fluorescent cell viability assay that can reduce interference from debris and residual red blood cells when validated with the intended instrument.

• Cefepime (BMY-28142) Research Workflows

  2026-09-14

  Build reproducible Cefepime assays for bacterial infection models, central nervous system infection research, and resistance dynamics. This guide combines fresh-solution handling, time-kill design, PKPD-informed sampling, and neurotoxicity-aware troubleshooting.

• Solanesol B8776: Practical Workflow Guide

  2026-09-13

  Solanesol B8776 provides a defined polyisoprenoid alcohol for hydrophobic biochemical, membrane-related, cell-based, and enzyme workflows. Its insolubility in water and ethanol requires DMSO-based preparation, fresh-solution handling, and solvent-matched controls; it is intended for research use only and not for diagnostic or medical applications.

• X-Gal Workflow for Blue-White Colony Screening

  2026-09-12

  Build a more reliable blue-white colony screening workflow with practical guidance on stock preparation, plating, readout, and troubleshooting. This article also shows how X-Gal-based clone triage can support complex recombinant DNA technology projects while keeping functional validation separate from visual selection.

• Novobiocin: A Translational Map for Antimicrobial Research

  2026-09-11

  A mechanistically grounded guide to positioning Novobiocin across antibacterial, antiparasitic, and antiviral research while separating target engagement, cellular phenotype, exposure, and translational maturity.

• Amitriptyline HCl: Protocol and QC Guide

  2026-09-11

  Amitriptyline HCl (SKU B2231) provides a defined small-molecule reference for receptor-inhibition profiling and related neuropharmacology research workflows. This guide covers dossier-based handling, solution preparation, QC, and interpretation boundaries; it should not be treated as evidence of efficacy in clinical studies or as a substitute for assay-specific validation.

• Carbapenemase Gene Transmission in CREC Hospitals

  2026-09-10

  This 2025 BMC Microbiology study maps carbapenemase-encoding genes, their genomic location, transferability, and strain relatedness in carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. Its combination of plasmid analysis, conjugation testing, antimicrobial susceptibility profiling, and ERIC-PCR shows how blaNDM-1-associated resistance can spread through both mobile elements and related clinical lineages.

• EPZ5676: A Selective DOT1L Inhibitor Workflow

  2026-09-10

  EPZ5676 combines subnanomolar biochemical potency with strong selectivity, making it useful for connecting DOT1L target engagement to H3K79 methylation, gene expression, and leukemia-cell phenotypes. This workflow also adapts emerging multiple myeloma findings to test innate immune signaling and lenalidomide response in a controlled research setting.

• BMS-777607 for MET and Platelet Research

  2026-09-09

  BMS-777607 provides a practical ATP-competitive probe for MET-family signaling, from c-Met phosphorylation assays to cancer metastasis models. Its most disciplined cross-domain use is as an exploratory perturbation alongside, not instead of, validated hiPSC platelet-differentiation conditions.

• NETs in CML and Differential TKI Effects

  2026-09-09

  The reference study identifies increased neutrophil extracellular trap formation as a feature of chronic myeloid leukemia and shows that tyrosine kinase inhibitors do not affect this response uniformly. Its combination of patient-derived neutrophils, a BCR-ABL1-transduced differentiation model, and pathway-directed inhibitors provides a useful framework for investigating links between kinase therapy, inflammation, and vascular toxicity.

• Otilonium Bromide: From Target to Assay Design

  2026-09-08

  Otilonium Bromide is an antimuscarinic agent for dissecting cholinergic signaling in neuronal and smooth-muscle models. This article connects receptor pharmacology, assay architecture, product handling, and lessons from structure-based inhibitor screening without overstating translational evidence.

• Fluorescein TSA Kit for Astrocyte Mapping

  2026-09-08

  Discover how the Fluorescein TSA Fluorescence System Kit can translate astrocyte atlas findings into sensitive spatial validation. This article connects regional and developmental heterogeneity with assay design, controls, and interpretation for IHC, ICC, and ISH.

8017 records 1/535 page Next 12345 下5页 Last page